Announcement February 11 these announcements are interesting

[product event]

Suna Co.Ltd(002417) attention letter: it is required to supplement the specific reasons for the decline of operating performance in 2021

Suna Co.Ltd(002417) (002417) received the attention letter from Shenzhen Stock Exchange. It is required to explain whether the company's fundamentals have changed significantly, supplement the specific reasons for the decline in operating performance in 2021, whether the decline in performance is sustainable, whether it has an adverse impact on the company's ability to continue operating, and give full risk tips.

Citic Securities Company Limited(600030) : purchase Hua Xia Bank Co.Limited(600015) three fixed-term deposits totaling 8 billion yuan

Citic Securities Company Limited(600030) (600030) announced that the company signed a deposit business agreement with Hua Xia Bank Co.Limited(600015) and purchased three fixed-term deposits, totaling 8 billion yuan.

Asymchem Laboratories (Tianjin) Co.Ltd(002821) : it is proposed to acquire the remaining equity of snapdragon company for us $57.94 million

Asymchem Laboratories (Tianjin) Co.Ltd(002821) (002821) announced that the company plans to acquire the equity held by 49 shareholders of snapdragon company in addition to the equity held by Asymchem Laboratories (Tianjin) Co.Ltd(002821) with its own capital of about US $57.94 million through merger. After the acquisition, Asymchem Laboratories (Tianjin) Co.Ltd(002821) will hold 100% equity of snapdragon. After the acquisition is completed, snapdragon will become the company's overseas R & D platform to further strengthen the company's R & D strength in the field of small molecule cdmo.

Chongqing Zhifei Biological Products Co.Ltd(300122) : lyophilized recombinant tuberculosis vaccine enters phase IIa clinical trial

Chongqing Zhifei Biological Products Co.Ltd(300122) (300122) announced that the company recently learned that the freeze-dried recombinant tuberculosis vaccine (AEC / bc02) developed by Anhui zhifeilong Kema biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, has completed phase I clinical research, and the preliminary results show that the vaccine has good safety and tolerance. At present, the preparation of phase IIa clinical trial of the product has been completed, the subject screening has been started, and the phase IIa clinical trial has been officially launched.

Ningbo Ligong Environment And Energy Technology Co.Ltd(002322) : since February 14, the abbreviation of securities has been changed to "science and Technology Department"

According to the announcement of Ningbo Ligong Environment And Energy Technology Co.Ltd(002322) (002322), since February 14, the securities abbreviation of the company has been changed from " Ningbo Ligong Environment And Energy Technology Co.Ltd(002322) " to "science and Technology Department", and the full name and securities code of the company remain unchanged.

Tederic Machinery Co.Ltd(603289) : it is proposed to invest 1.3 billion yuan to build the intelligent manufacturing base project of injection molding equipment

Tederic Machinery Co.Ltd(603289) (603289) announced that the company plans to change the wholly-owned subsidiary Zhejiang Tairui Precision Machinery Co., Ltd. to Zhejiang Tairui Equipment Co., Ltd. (hereinafter referred to as "Zhejiang Tairui"), and Zhejiang Tairui is responsible for the investment and construction of injection molding equipment intelligent manufacturing base project. The total investment of the project is expected to be 1.3 billion yuan, which is mainly used for the R & D, production and sales of medium and high-end intelligent injection molding machine and its key parts.

Shandong Buchang Pharmaceuticals Co.Ltd(603858) : the holding subsidiary approved the clinical trial of recombinant human parathyroid hormone for injection (1-84)

Shandong Buchang Pharmaceuticals Co.Ltd(603858) (603858) announced that Luzhou Buchang injection recombinant human parathyroid hormone (1-84), a holding subsidiary of the company, obtained the notice of approval for drug clinical trial.

Bank Of Changsha Co.Ltd(601577) : approved to issue special financial bonds for small and micro enterprise loans of no more than 5 billion yuan

Bank Of Changsha Co.Ltd(601577) (601577) announced that the bank was allowed to issue special financial bonds for small and micro enterprise loans of no more than 5 billion yuan in the national inter-bank bond market.

Beijing Bewinner Communications Co.Ltd(002148) : it is proposed to subscribe for the directional issuance shares

Beijing Bewinner Communications Co.Ltd(002148) (002148) announced that the company plans to invest 10 million yuan to subscribe for 7812500 shares issued by Beijing Xinlian Chuangzhan Electronic Technology Co., Ltd. (hereinafter referred to as "Xinlian Chuangzhan"), a new third board listed company, at a subscription price of 12.8 yuan / share. After the completion of this investment, the company plans to hold 11.111% of the shares of Xinlian Chuangzhan. Xinlian Innovation Exhibition is a professional RFID (radio frequency identification) technology and product service provider in the field of Internet of things. This investment effectively helps the development of the company's Internet of things business.

Henan Dayou Energy Co.Ltd(600403) : it is proposed to invest 1.88 billion yuan in the wholly-owned subsidiary of Yuneng

According to the announcement of Henan Dayou Energy Co.Ltd(600403) (600403), the board of directors of the company considered and passed the proposal and agreed that the company would increase the capital of its wholly-owned subsidiary, Yuneng investment, by means of debt to equity swap, with a capital increase amount of 1.88 billion yuan. After the capital increase, the registered capital of Yuneng investment was 2.38 billion yuan.

Harbin Pharmaceutical Group Co.Ltd(600664) : ampicillin sodium for injection passed the conformity evaluation of generic drugs

Harbin Pharmaceutical Group Co.Ltd(600664) (600664) announcement: Recently, Harbin Pharmaceutical General Factory, a branch of the company, received the notice of approval for supplementary application of drugs for ampicillin sodium for injection issued by the State Food and drug administration. The drug passed the consistency evaluation of quality and efficacy of generic drugs.

Shanghai Lujiazui Finance & Trade Zone Development Co.Ltd(600663) : 5 billion yuan medium-term notes approved for registration

Shanghai Lujiazui Finance & Trade Zone Development Co.Ltd(600663) (600663) announced that recently, the company received a notice issued by the Dealer Association, which decided to accept the registration of the company's medium-term notes. The registered amount of the company's medium-term notes is 5 billion yuan, and the registered amount is valid within 2 years from the date of signing the notice.

Yahong medicine: haikewei was approved to carry out phase III clinical trial

Yahong Pharmaceutical (688176) announced that recently, the company's drug haikewei obtained the notice of approval for drug clinical trial issued by the State Drug Administration (nmpa). Hai Wei Wei is currently the world's only approved adjuvant bladder cancer diagnosis or operation of the development of drugs.

Zhejiang Tianyu Pharmaceutical Co.Ltd(300702) : the subsidiary losartan potassium API obtained CEP certificate

Zhejiang Tianyu Pharmaceutical Co.Ltd(300702) (300702) announced that Jingsheng pharmaceutical, a wholly-owned subsidiary of the company, has received the European Pharmacopoeia suitability certification certificate for losartan potassium API (hereinafter referred to as "CEP certificate") issued by the European drug quality administration. Losartan potassium is a drug used to treat essential hypertension.

Shandong Sunway Chemical Group Co.Ltd(002469) : the first phase of the technical transformation project of high-end catalyst with an annual output of 10000 tons was completed and put into operation

Shandong Sunway Chemical Group Co.Ltd(002469) (002469) announced that the company will build a 10000 t / a high-end catalyst technical transformation project in two phases, and the unit capacity in phase I and phase II is 5000 t / A. At present, the construction, equipment installation and commissioning involved in phase I of the project have been completed, and the commissioning has been put into operation and qualified products have been produced.

Tasly Pharmaceutical Group Co.Ltd(600535) : the 300L fermentation scale cell culture production line of recombinant human prourokinase for injection was approved

Tasly Pharmaceutical Group Co.Ltd(600535) (600535) announced that Tasly Pharmaceutical Group Co.Ltd(600535) biological, the holding subsidiary of the company, received the notification of on-site inspection results of drug production issued by Shanghai Drug Administration and the notification of approval of drug supplementary application issued by the State Drug Administration on the 300L fermentation scale cell culture production line of recombinant human urokinase for injection (trade name "puyouke").

Shanghai Huafon Aluminium Corporation(601702) : it is proposed to invest 1.98 billion yuan in the construction of high-end aluminum sector, strip and foil project for new energy vehicles

Shanghai Huafon Aluminium Corporation(601702) (601702) announced that the company plans to invest in the construction of high-end aluminum sector, strip and foil project for new energy vehicles with an annual output of 150000 tons through Chongqing Huafeng, a wholly-owned subsidiary, with an estimated total investment of 1.98 billion yuan, of which the total amount of funds raised by non-public offering of shares does not exceed 1 billion yuan.

Jiangsu Hengrui Medicine Co.Ltd(600276) : the two drugs obtained the drug registration certificate

Jiangsu Hengrui Medicine Co.Ltd(600276) (600276) announced that ondansetron oral film and paracetamol mannitol injection of the company have obtained the drug registration certificate

[performance]

Beiqi Foton Motor Co.Ltd(600166) : the sales volume of new energy vehicles in January increased by 256.75% year-on-year

Beiqi Foton Motor Co.Ltd(600166) (600166) announced that the sales volume of automobile products in January was 41445, a year-on-year decrease of 32.15%. Among them, the sales volume of new energy vehicles was 899, with a year-on-year increase of 256.75%. In addition, the company received 482 million yuan of national new energy vehicle promotion subsidy transferred by Beijing Municipal Bureau of finance.

Jiangxi Zhengbang Technology Co.Ltd(002157) : pig sales revenue in January decreased by 5.57% month on month

Jiangxi Zhengbang Technology Co.Ltd(002157) (002157) announced that the company sold 958700 pigs in January (including 69800 piglets and 888900 commercial pigs), up 19.07% month on month and 21.86% year-on-year; The sales revenue was 1.219 billion yuan, a month on month decrease of 5.57% and a year-on-year decrease of 60.92%. The average selling price of commercial pigs (excluding piglets) was 12.92 yuan / kg, down 14.89% from the previous month; The average weight was 105.13 kg / head, down 3.83% from the previous month.

Anhui Jianghuai Automobile Group Corp.Ltd(600418) : the sales volume in January decreased by 10.64% year-on-year

Anhui Jianghuai Automobile Group Corp.Ltd(600418) (600418) disclosed the production and sales express in January. The output in January was 51361, a year-on-year decrease of 10.17%; The sales volume was 51558, a year-on-year decrease of 10.64%. In addition, within three months after 15 trading days from the date of announcement, the shareholders' construction investment plan will reduce the shares of the company by means of centralized bidding, which will not exceed 1% of the total shares of the company, i.e. 21.84 million shares.

Tecon Biology Co.Ltd(002100) : pig sales revenue in January decreased by 17.33% month on month

Tecon Biology Co.Ltd(002100) (002100) announced that 126900 pigs were sold in January, with a month on month decrease of 13.85% and a year-on-year decrease of 15.96%; The sales revenue was 186 million yuan, with a month on month decrease of 17.33% and a year-on-year decrease of 52.31%. In January 2022, the average selling price of commercial pigs (excluding piglets and breeding pigs) was 12.49 yuan / kg, with an average weight of 118.70 kg. The main reason for the year-on-year decline in sales revenue is that the market price of pigs has fallen significantly compared with the same period last year.

China Suntien Green Energy Corporation Limited(600956) : the power generation completed in January was 1188100 megawatt hours, a year-on-year decrease of 16.98%

According to the announcement of China Suntien Green Energy Corporation Limited(600956) (600956), according to the preliminary statistics of the company, in January 2022, the company and its subsidiaries completed 1188100 MW of power generation according to the consolidated statement, a year-on-year decrease of 16.98%.

Shandong Minhe Animal Husbandry Co.Ltd(002234) : the sales revenue of commercial substitute chicken seedlings in January increased by 38.17% month on month

Shandong Minhe Animal Husbandry Co.Ltd(002234) (002234) announced that the company sold 23.842 million commercial substitute chicken seedlings in January, with a year-on-year change of 5.30% and a month on month change of 87.81%; The sales revenue was RMB 278800, with a year-on-year change of -17.42%. The main reason for the month on month increase in sales is that the output was low due to the suspension of incubation last month. The commercial substitute chicken seedlings began to be produced and sold normally in January; The year-on-year decrease in sales revenue is mainly due to the low average sales price of chicken seedlings in this period.

Dongrui Food Group Co.Ltd(001201) : pig sales revenue in January increased by 2.76% month on month

Dongrui Food Group Co.Ltd(001201) (001201) announced that in January, the company sold 46600 pigs, including 29200 commercial pigs, 15600 piglets, 13000 eliminated breeding pigs and 0500 breeding pigs. The sales revenue was 78 million yuan, up 2.76% month on month. In January, the average selling price of the company's commercial pigs was 20.06 yuan / kg, down 0.41% month on month.

Wens Foodstuff Group Co.Ltd(300498) : the sales revenue of pigs in January increased by 7.86% month on month

According to the announcement of Wens Foodstuff Group Co.Ltd(300498) (300498), 1.5061 million pigs (including hairy pigs and fresh products) were sold in January, with an income of 2.471 billion yuan. The average sales price of hairy pigs was 14.09 yuan / kg, with month on month changes of 22.75%, 7.86% and - 13.08% respectively, and year-on-year changes of 50.01%, 39.29% and - 58.79% respectively. In January, 90.1984 million broilers (including wool chicken, fresh products and cooked food) were sold, with an income of 2.635 billion yuan. The average sales price of wool chicken was 13.98 yuan / kg, with month on month changes of - 5.63%, - 8.57% and - 4.25% respectively, and year-on-year changes of 6%, 8.26% and - 0.14% respectively. 24.1867 million white feather chicken seedlings were sold in January.

Shanghai Hanbell Precise Machinery Co.Ltd(002158) performance express: the net profit in 2021 was 487 million yuan, with a year-on-year increase of 34.05%

Shanghai Hanbell Precise Machinery Co.Ltd(002158) (002158) released the performance express. In 2021, the operating revenue was 2.981 billion yuan, a year-on-year increase of 31.21%; The net profit attributable to the parent company was 487 million yuan, a year-on-year increase of 34.05%; The basic earnings per share is 0.91 yuan. In 2021, the company did a solid job in production and operation, strengthened marketing, and actively developed new energy-saving and environmental protection products, resulting in an increase in sales revenue over the same period of last year, resulting in an increase in net profit over the same period of last year

[increase / decrease]

Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) : several shareholders plan to reduce their shares by no more than 7.3862%

Zhuzhou Huarui Precision Cutting Tools.Co.Ltd(688059) (688059) announced that the shareholders Qingdao Liuhe, Xi'an Liuhe, Xia Xiaohui, Wang Ye and Zhuo Xiaofan plan to reduce their total holdings of no more than 7.3862% of the company's shares.

Beijing Kawin Technology Share-Holding Co.Ltd(688687) : the shareholder Jun Ruiqi plans to reduce his shareholding of no more than 5%

Beijing Kawin Technology Share-Holding Co.Ltd(688687) (688687) announced that junruiqi, a shareholder with a shareholding of 8.43%, plans to reduce its total shares of the company by means of block trading and centralized bidding, which will not exceed 8.491 million shares, that is, not more than 5.00% of the total share capital of the company.

Panda Dairy Corporation(300898) : the directors and their unanimous persons intend to reduce their shares by no more than 2%

Panda Dairy Corporation(300898) (300898) announced that Guo Hong, the major shareholder and director of the company, and Zhou Wei, the person acting in concert, plan to reduce 2499600 shares of the company (accounting for 2% of the total share capital of the company) by means of centralized bidding within 6 months after 15 trading days from the date of disclosure of the announcement.

Shenzhen Jiang&Associates Creative Design Co.Ltd(300668) : the actual controller intends to reduce the holding of no more than 2% shares

Shenzhen Jiang&Associates Creative Design Co.Ltd(300668) (300668) announced that the controlling shareholder and actual controller Jiang Feng, who holds 47.35 million shares of the company (accounting for 39.34% of the total share capital of the company), plans to reduce the shares of the company by means of centralized bidding and block trading, with a reduction of no more than 2407600 shares (accounting for 2% of the total share capital of the company)

[repurchase]

Shenzhen Goodix Technology Co.Ltd(603160) : it is proposed to repurchase shares with RMB 400 million to RMB 500 million

Shenzhen Goodix Technology Co.Ltd(603160) (603160) announced that the company plans to repurchase shares with 400 million yuan to 500 million yuan, and the repurchase price shall not exceed 126 yuan / share

[signature]

Porton Pharma Solutions Ltd(300363) : received US $681 million purchase order from Pfizer's company

Porton Pharma Solutions Ltd(300363) (300363) announced that recently, the company received from multinational pharmaceutical company Pfizer Inc. (hereinafter referred to as "Pfizer") will provide contract customized R & D and production (cdmo) services for the new batch of purchase orders of Pfizer Ireland pharmaceuticals, and the order delivery time is 2022. As of the disclosure date of the announcement, the total amount of newly obtained orders was 681 million US dollars, exceeding 50% of the audited operating revenue of the company in the latest fiscal year.

Intco Medical Technology Co.Ltd(300677) : the subsidiary plans to participate in the investment fund of US $100 million

Intco Medical Technology Co.Ltd(300677) (300677) announced that the wholly-owned subsidiary of the company in Singapore plans to sign the subscription agreement with Warburg Pincus capital to invest its own funds in Warburg Pincus global growth 14, L.P. (the "partnership"). The partnership's target total subscribed capital contribution is US $16 billion, of which the Singapore company will subscribe US $100 million as the limited partner (LP) of the partnership. The investment direction of the partnership is growth capital, early growth platform, company acquisition and capital restructuring investment in business services, financial services, health care, industry, science and technology, real estate and energy.

Hunan Development Group Co.Ltd(000722) : the proposed Sun company cooperates to develop distributed photovoltaic project

Hunan Development Group Co.Ltd(000722) (000722) announced that Hunan Development Group Co.Ltd(000722) hydropower company, a wholly-owned subsidiary of the company, plans to establish a wholly-owned subsidiary Hunan Development Group Co.Ltd(000722) Lukou New Energy Development Co., Ltd. After the establishment of the new company, it plans to sign a cooperation contract with Lukou industrial development group. The two sides use the roof of phase I standard plant and Sanlian plant in Nanzhou Industrial Park, Lukou District, Zhuzhou City to jointly develop a distributed photovoltaic project, with a total roof area of 36873 square meters and a planned total installed capacity of 4.4451 MW. The total investment of the project is about 21.075 million yuan, and the financial internal rate of return of the project is 6.04% (after tax).

No less than RMB 123600 {123600} planned to be built in Guilin {phase II}

Lingyi Itech (Guangdong) Company(002600) (002600) announced that the company plans to sign the cooperation agreement on Guilin Lingyi Itech (Guangdong) Company(002600) intelligent manufacturing project (phase II) with Guilin Municipal People's Government in Guilin. The company will invest in the construction of Guilin Lingyi Itech (Guangdong) Company(002600) intelligent manufacturing project (phase II) in Guilin economic and Technological Development Zone, and increase the business of consumer electronics supporting charging modules outside the scope of the previous cooperation, Guilin Municipal People's government will designate Guilin economic and Technological Development Zone to communicate information with the company and promote cooperation. The total planned investment of the company is no less than 2 billion yuan, of which about 1.5 billion yuan is invested in fixed assets.

Decai Decoration Co.Ltd(605287) : the subsidiaries jointly won the bid of 176 million yuan Shaohai talent innovation and entrepreneurship Park project

Decai Decoration Co.Ltd(605287) (605287) announced that the joint venture of Qingdao CSCEC United Group Co., Ltd. and Qingdao Beiyang Architectural Design Co., Ltd., a subsidiary of the company, is expected to win the bid for bid section 1 of the general contracting for the design and construction of Shaohai talent innovation and entrepreneurship Park Project (underground parking garage of talent Park), with an estimated bid winning amount of 176 million yuan (including tax).

- Advertisment -